HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gwangil Kim Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

8/2013Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gwangil Kim Research Topics

Disease

12Neoplasms (Cancer)
10/2020 - 05/2011
8Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 11/2010
7Carcinoma (Carcinomatosis)
08/2021 - 05/2011
4Neoplasm Metastasis (Metastasis)
05/2022 - 05/2011
3Breast Neoplasms (Breast Cancer)
01/2017 - 08/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 01/2016
2Pathologic Constriction (Stenosis)
02/2022 - 01/2022
2Fibrosis (Cirrhosis)
02/2022 - 06/2017
2Bites and Stings (Sting)
01/2019 - 01/2019
2Adenocarcinoma
05/2016 - 08/2014
1Congenital Abnormalities (Deformity)
02/2022
1Infections
05/2019
1Vascular Remodeling
01/2019
1Abdominal Pregnancy
07/2017
1Tubal Pregnancy
07/2017
1Amenorrhea
07/2017
1Hemorrhage
07/2017
1Lung Neoplasms (Lung Cancer)
01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1Adenocarcinoma of Lung
01/2016
1Stomach Ulcer (Gastric Ulcer)
04/2015
1Ulcer
04/2015
1Endometrial Stromal Sarcoma
12/2014
1Carcinogenesis
08/2014
1Leukemia
08/2013
1Stomach Neoplasms (Stomach Cancer)
10/2012
1Disease Progression
05/2011
1Lymphatic Metastasis
05/2011

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2017 - 05/2011
3MicroRNAs (MicroRNA)IBA
05/2022 - 11/2010
3ParaffinIBA
04/2021 - 05/2011
3Formaldehyde (Formol)FDA Link
04/2021 - 05/2011
3Indicators and Reagents (Reagents)IBA
04/2021 - 10/2012
3Paclitaxel (Taxol)FDA LinkGeneric
09/2017 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2015 - 11/2010
2InterferonsIBA
01/2019 - 01/2019
2Interferon Type IIBA
01/2019 - 01/2019
2Small Interfering RNA (siRNA)IBA
01/2016 - 03/2014
1RNA (Ribonucleic Acid)IBA
08/2021
1micaIBA
04/2021
1LigandsIBA
04/2021
1pembrolizumabIBA
10/2020
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1LuciferasesIBA
09/2017
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
07/2017
1Fibronectins (Fibronectin)IBA
06/2017
1Troglitazone (Rezulin)FDA Link
06/2017
1Rosiglitazone (Avandia)FDA Link
06/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2017
1fascinIBA
01/2017
1Transcription Factors (Transcription Factor)IBA
05/2016
1Messenger RNA (mRNA)IBA
02/2016
1human MIRN1290 microRNAIBA
01/2016
1Serum-Free Culture MediaIBA
01/2016
1human MIRN1246 microRNAIBA
01/2016
1Pharmaceutical PreparationsIBA
04/2015
1Drug CombinationsIBA
04/2015
1Phenobarbital (Luminal)FDA Link
03/2015
1Oncogene Proteins (Oncogene Protein)IBA
01/2015
1CarcinogensIBA
08/2014
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2013
1Biological ProductsIBA
08/2013
1Lysine (L-Lysine)FDA Link
08/2013
1Fluorouracil (Carac)FDA LinkGeneric
08/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2013
1CyclinsIBA
05/2011
1Cell Cycle ProteinsIBA
05/2011
1Cyclin AIBA
05/2011
1Cyclin EIBA
05/2011
1Cyclin-Dependent Kinase Inhibitor p16IBA
05/2011
1Cyclin B1IBA
05/2011

Therapy/Procedure

3Therapeutics
08/2021 - 04/2015
1Stents
02/2022
1Radiofrequency Ablation
01/2022
1Pancreaticoduodenectomy
06/2019
1Surgical Instruments (Clip)
05/2019
1Immunotherapy
01/2019
1Conservative Treatment
07/2017
1Drug Therapy (Chemotherapy)
01/2016
1Aftercare (After-Treatment)
01/2016
1Photochemotherapy (Photodynamic Therapy)
12/2014